The effect of zidovudine on chronic myelopathy associated with HTLV-1
- 1 April 1991
- journal article
- letter
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 238 (2) , 108-109
- https://doi.org/10.1007/bf00315691
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.Proceedings of the National Academy of Sciences, 1990
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- HIGH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I PROVIRAL DNA LOAD WITH POLYCLONAL INTEGRATION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF FRENCH WEST-INDIAN, GUIANESE, AND AFRICAN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS1990
- High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesisBlood, 1990
- Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.Journal of Clinical Investigation, 1987